Skip to content
healthcare.dev

Avalide

NDC 0024-5855, irbesartan and hydrochlorothiazide, tablet, film coated, from Sanofi-Aventis U.S. LLC.

Product NDC
0024-5855
Status
Listed
Labeler
Sanofi-Aventis U.S. LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020758
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5855 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN150 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
0024-5855-300002458553030 TABLET, FILM COATED in 1 BOTTLE (0024-5855-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0d91895e-c869-4b33-9b83-d55c1ad6317e

Use it

Look up 0024-5855 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5855 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0024-5855. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.